Gênica Inovação Biotecnológica
PrivateLast Round
Series C
Jun 26, 2024
Est. Valuation
$100M
Total Funding Raised
$16.24M
Company Overview
Gênica Inovação Biotecnológica operates in Healthcare & Life Sciences and is based in Piracicaba. Its latest recorded funding round was a Series C round in June 2024.
Gênica Inovação Biotecnológica is a biotechnology company that develops and provides bio-inputs and regenerative solutions for the agricultural sector.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gênica Inovação Biotecnológica Comparables
Compare Gênica Inovação Biotecnológica with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Agrivalle Brasil | 88% | |
| Simbiose Agro | 87% | |
| Ballagro Agro Tecnologia | 86% |
For institutional investors. Book with your work email.
Gênica Inovação Biotecnológica Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jun 26, 2024 | ||||
| Series B | May 10, 2022 | ||||
| Seed | Jan 1, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Gênica Inovação Biotecnológica Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SP Ventures | Series B, Series C, Seed |
| Vox Capital | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 26, 2024
$12M round led by Mitsubishi Corporation (Americas)
- Nov 16, 2023
Grew 24% QoQ, from 149 to 185 employees.
For institutional investors. Book with your work email.
Gênica Inovação Biotecnológica Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Gênica Inovação Biotecnológica's valuation, stock price, and market status.
Is Gênica Inovação Biotecnológica a public or private company?
Gênica Inovação Biotecnológica is a private company.
What is the current stock price of Gênica Inovação Biotecnológica?
Gênica Inovação Biotecnológica is a private company, so its shares have no public market price. Caplight tracks Gênica Inovação Biotecnológica's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Gênica Inovação Biotecnológica worth (valuation)?
Gênica Inovação Biotecnológica's valuation is estimated at $100.0M based on funding round data.
Can I buy Gênica Inovação Biotecnológica stock?
Gênica Inovação Biotecnológica shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Gênica Inovação Biotecnológica's last funding round?
Gênica Inovação Biotecnológica's most recent funding round was Series C on June 26, 2024.
Who are the main investors in Gênica Inovação Biotecnológica?
Key investors in Gênica Inovação Biotecnológica include SP Ventures.
Will Gênica Inovação Biotecnológica IPO soon?
No public IPO plans have been announced for Gênica Inovação Biotecnológica.
How can I track Gênica Inovação Biotecnológica secondary market activity?
Caplight tracks bids, offers, and trades in Gênica Inovação Biotecnológica's shares on secondary markets.